3 hours Brookline Capital Management Comments on Immunic, Inc.’s Q4 2025 Earnings (NASDAQ:IMUX)MarketBeat
Immunic, Inc. (NASDAQ:IMUX – Free Report) – Stock analysts at Brookline Capital Management issued their Q4 2025 earnings per share (EPS) estimates for shares of Immunic in a note issued to investors on Tuesday, October 15th. Brookline Capital Manage…
X